The Department of Veterans Affairs is issuing a Notice of Intent to Sole Source a contract for the procurement of seven Fluency Stents from Bard Peripheral Vascular, Inc. This action, under solicitation number 36C24125Q0255, is due by February 12, 2025, at 4:00 PM EST. The procurement will follow FAR 813.106-1(b) guidelines for Simplified Acquisition, indicating that the government intends to negotiate exclusively with Bard San Resilient. All parties interested in providing these products are invited to submit their qualifications by the specified deadline to the designated Contract Specialist, Divianna Mathurin. The document emphasizes that this notice does not constitute a competitive solicitation and responses will be used for market research purposes only. The goal is to ascertain whether a competitive procurement process is warranted, though the decision rests solely with the government. This summary reveals the VA's intent to streamline procurement for essential medical supplies while ensuring compliance with federal acquisition regulations.
The document outlines a Justification for Single Source Awards by the Department of Veterans Affairs (VA) for the acquisition of seven Fluency Plus Endovascular Stent Grafts. These stents, manufactured solely by Bard Peripheral Vascular, Inc., are specifically required for use in the Interventional Radiology Service at the Providence VA Medical Center due to their FDA approval for treating dialysis fistulas and grafts. The justification asserts that these stents have demonstrated superior performance over alternative products, making them the only suitable option for the required procedures. Market research confirmed that Bard is the only vendor authorized to supply these unique stents, with the research encompassing various government databases. The document includes a certification from the contracting officer, Phillip Crockett, affirming compliance with acquisition regulations. This procurement is essential for maintaining patient care within the VA system and reducing reliance on external community care for veterans. The focus is on ensuring high-quality patient outcomes through the exclusive use of these specific stents in expanding interventional services.